Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Total article views   HTML views PDF downloads Totals
9,868 Dovepress* 7,028+ 541 7,569
PubMed Central* 2,840 702 3,542
Totals 9,868 1,243 11,111
*Since 30 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar